[
    [
        {
            "time": "2018-06-30",
            "original_text": "复星国际上半年净利润68.6亿元 健康板块利润增长31.2%",
            "features": {
                "keywords": [
                    "复星国际",
                    "净利润",
                    "健康板块",
                    "利润增长"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星国际上半年净利润68.6亿元 健康板块利润增长31.2%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-29",
            "original_text": "【盘前看市】等待缩量回调机会 低吸超跌白马股和科技股",
            "features": {
                "keywords": [
                    "盘前看市",
                    "缩量回调",
                    "白马股",
                    "科技股"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "消费"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【盘前看市】等待缩量回调机会 低吸超跌白马股和科技股",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-06-30",
            "original_text": "复星医药2018年上半年营收、研发投入双增长，海外布局效应明显",
            "features": {
                "keywords": [
                    "复星医药",
                    "营收增长",
                    "研发投入",
                    "海外布局"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药2018年上半年营收、研发投入双增长，海外布局效应明显",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-08-29",
            "original_text": "持仓全貌曝光 基金继续青睐消费股",
            "features": {
                "keywords": [
                    "基金",
                    "消费股",
                    "持仓"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "持仓全貌曝光 基金继续青睐消费股",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-29",
            "original_text": "8月29日券商晨会研报汇编",
            "features": {
                "keywords": [
                    "券商晨会",
                    "研报汇编"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "8月29日券商晨会研报汇编",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-29",
            "original_text": "【医药-崔文亮】复星医药：非经常性投资收益下滑及费用率上升拖累公司业绩，研发迎来收获期 盈利能力下降",
            "features": {
                "keywords": [
                    "复星医药",
                    "投资收益下滑",
                    "费用率上升",
                    "盈利能力下降",
                    "研发收获期"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【医药-崔文亮】复星医药：非经常性投资收益下滑及费用率上升拖累公司业绩，研发迎来收获期 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]